Genome-wide DNA methylation analysis in multiple tissues in primary Sjögren's syndrome reveals regulatory effects at interferon-induced genes

Annals of the Rheumatic Diseases

Volumn 75, Issue 11, 2016, Pages 2029-2036

  Imgenberg Kreuz, Juliana ^a   Sandling, Johanna K ^a   Almlöf, Jonas Carlsson ^a   Nordlund, Jessica ^a   Signér, Linnea ^a   Norheim, Katrine Braekke ^b   Omdal, Roald ^b   Rönnblom, Lars ^a   Eloranta, Maija Leena ^a   Syvänen, Ann Christine ^a   Nordmark, Gunnel ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Autoimmunity; B cells; Gene Polymorphism; Sj gren's Syndrome

Indexed keywords

CD19 ANTIGEN; HISTONE; INTERFERON; MESSENGER RNA; 2',5' OLIGOADENYLATE SYNTHETASE; 2',5'-OLIGOADENYLATE SYNTHETASE 2, HUMAN; ANTIGEN; CYTOSKELETON PROTEIN; IFI44 PROTEIN, HUMAN; MX1 PROTEIN, HUMAN; MYXOVIRUS RESISTANCE PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARP9 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DNA METHYLATION; ENHANCER REGION; EPIGENETICS; FEMALE; GENE; GENE EXPRESSION; GENE LOCUS; GENETIC REGULATION; GENETIC RISK; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IFI44L GENE; MAJOR CLINICAL STUDY; MALE; MX1 GENE; OAS2 GENE; PARP9 GENE; PRIMARY SJOEGREN SYNDROME; PRIORITY JOURNAL; PROMOTER REGION; SALIVARY GLAND BIOPSY; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME; AGED; BLOOD; CASE CONTROL STUDY; GENETIC EPIGENESIS; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MIDDLE AGED; MINOR SALIVA GLAND; PATHOLOGY;

2',5'-OLIGOADENYLATE SYNTHETASE; ADULT; AGED; ANTIGENS; ANTIGENS, CD19; CASE-CONTROL STUDIES; CYTOSKELETAL PROTEINS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTERFERONS; MALE; MIDDLE AGED; MYXOVIRUS RESISTANCE PROTEINS; NEOPLASM PROTEINS; POLY(ADP-RIBOSE) POLYMERASES; SALIVARY GLANDS, MINOR; SJOGREN'S SYNDROME;

EID: 84958068675     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2015-208659     Document Type: Article

References (46)

1. Jonsson R, Bolstad AI, Brokstad KA, et al. Sjogrens syndrome-A plethora of clinical and immunological phenotypes with a complex genetic background. Ann N Y Acad Sci 2007;1108:433-47.
2. Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjögrens syndrome. Nat Rev Rheumatol 2013;9:544-56.
3. Bave U, Nordmark G, Lövgren T, et al. Activation of the type I interferon system in primary Sjögrens syndrome: A possible etiopathogenic mechanism. Arthritis Rheum 2005;52:1185-95.
4. Gottenberg JE, Cagnard N, Lucchesi C, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögrens syndrome. Proc Natl Acad Sci USA 2006;103:2770-5.
5. Hjelmervik TO, Petersen K, Jonassen I, et al. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögrens syndrome patients from healthy control subjects. Arthritis Rheum 2005;52:1534-44.
6. Emamian ES, Leon JM, Lessard CJ, et al. Peripheral blood gene expression profiling in Sjögrens syndrome. Genes Immun 2009;10:285-96.
7. Brkic Z, Maria NI, van Helden-Meeuwsen CG, et al. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögrens syndrome and association with disease activity and BAFF gene expression. Ann Rheum Dis 2013;72:728-35.
8. Theander E, Henriksson G, Ljungberg O, et al. Lymphoma and other malignancies in primary Sjögrens syndrome: A cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006;65:796-803.
9. Lessard CJ, Li H, Adrianto I, et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögrens syndrome. Nat Genet 2013;45:1284-92.
10. Li Y, Zhang K, Chen H, et al. A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögrens syndrome at 7q11.23. Nat Genet 2013;45:1361-5.
11. Ice JA, Li H, Adrianto I, et al. Genetics of Sjögrens syndrome in the genome-wide association era. J Autoimmun 2012;39:57-63.
12. Konsta OD, Thabet Y, Le Dantec C, et al. The contribution of epigenetics in Sjögrens Syndrome. Front Genet 2014;5:71.
13. Bibikova M, Barnes B, Tsan C, et al. High density DNA methylation array with single CpG site resolution. Genomics 2011;98:288-95.
14. Altorok N, Coit P, Hughes T, et al. Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sjögrens syndrome. Genomics 2014;66:731-9.
15. Miceli-Richard C, Wang-Renault SF, Boudaoud S, et al. Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sjogrens syndrome. Ann Rheum Dis 2016;75:933-40.
16. Bernstein BE, Stamatoyannopoulos JA, Costello JF, et al. The NIH Roadmap Epigenomics Mapping Consortium. Nat Biotechnol 2010;28:1045-8.
17. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogrens syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
18. Nordmark G, Wang C, Vasaitis L, et al. Association of genes in the NF-kB pathway with antibody-positive primary Sjogrens syndrome. Scand J Immunol 2013;78:447-54.
19. Berggren O, Alexsson A, Morris DL, et al. IFN-Alpha production by plasmacytoid dendritic cell associations with polymorphisms in gene loci related to autoimmune and inflammatory diseases. Hum Mol Genet 2015;24:3571-81.
20. R Core Development Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2011.
21. Aryee MJ, Jaffe AE, Corrada-Bravo H, et al. Minfi: A flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 2014;30:1363-9.
22. Maksimovic J, Gordon L, Oshlack A. SWAN: Subset-quantile within array normalization for illumina infinium HumanMethylation450 BeadChips. Genome Biol 2012;13:R44.
23. Houseman EA, Accomando WP, Koestler DC, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC bioinformatics 2012;13:86.
24. Reinius LE, Acevedo N, Joerink M, et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS ONE 2012;7:e41361.
25. DeLuca DS, Levin JZ, Sivachenko A, et al. RNA-SeQC: RNA-seq metrics for quality control and process optimization. Bioinformatics 2012;28:1530-2.
26. Trapnell C, Roberts A, Goff L, et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 2012;7:562-78.
27. Kim D, Pertea G, Trapnell C, et al. TopHat2: Accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 2013;14:R36.
28. Purcell S, Neale B, Todd-Brown K, et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75.
29. Haller O, Kochs G. Human MxA protein: An interferon-induced dynamin-like GTPase with broad antiviral activity. J Interferon Cytokine Res 2011;31:79-87.
30. Wang SS, Betz AG, Reed RR. Cloning of a novel Olf-1/EBF-like gene, O/E-4, by degenerate oligo-based direct selection. Mol Cell Neurosci 2002;20:404-14.
31. Hovanessian AG, Justesen J. The human 20-50oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 20-50 instead of 30-50 phosphodiester bond formation. Biochimie 2007;89:779-88.
32. Nordmark G, Eloranta ML, Ronnblom L. Primary Sjogrens syndrome and the type I interferon system. Curr Pharm Biotechnol 2012;13:2054-62.
33. Nezos A, Gravani F, Tassidou A, et al. Type I and II interferon signatures in Sjogrens syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjogrens related lymphomagenesis. J Autoimmun 2015;63:47-58.
34. Rönnblom L, Alm GV, Eloranta ML. The type I interferon system in the development of lupus. Semin Immunol 2011;23:113-21.
35. Maria NI, Brkic Z, Waris M, et al. MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogrens syndrome. Ann Rheum Dis 2014;73:1052-9.
36. Coit P, Jeffries M, Altorok N, et al. Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naive CD4+ T cells from lupus patients. J Autoimmun 2013;43:78-84.
37. Absher DM, Li X, Waite LL, et al. Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet 2013;9:e1003678.
38. Zhao M, Liu S, Luo S, et al. DNA methylation and mRNA and microRNA expression of SLE CD4+ T cells correlate with disease phenotype. J Autoimmun 2014;54:127-36.
39. Coit P, Yalavarthi S, Ognenovski M, et al. Epigenome profiling reveals significant DNA demethylation of interferon signature genes in lupus neutrophils. J Autoimmun 2015;58:59-66.
40. Nordmark G, Kristjansdottir G, Theander E, et al. Association of EBF1, FAM167A (C8orf13)-BLK and TNFSF4 gene variants with primary Sjögrens syndrome. Genes Immun 2011;12:100-9.
41. Camicia R, Bachmann SB, Winkler HC, et al. BAL1/ARTD9 represses the anti-proliferative and pro-Apoptotic IFNg-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma. J Cell Sci 2013;126(Pt 9):1969-80.
42. Baecklund E, Smedby KE, Sutton LA, et al. Lymphoma development in patients with autoimmune and inflammatory disorders-what are the driving forces? Semin Cancer Biol 2014;24:61-70.
43. Lev Maor G, Yearim A, Ast G. The alternative role of DNA methylation in splicing regulation. Trends Genet 2015;31:274-80.
44. Graves M, Benton M, Lea R, et al. Methylation differences at the HLA-DRB1 locus in CD4+ T-Cells are associated with multiple sclerosis. Mult Scler 2013;20:1033-41.
45. Haneklaus M, Gerlic M, ONeill LA, et al. miR-223: infection, inflammation and cancer. J Intern Med 2013;274:215-26.
46. Alevizos I, Alexander S, Turner RJ, et al. MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögrens syndrome. Arthritis Rheum 2011;63:535-44.